Kangstem Biotech Co. Ltd (217730) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.056x

Based on the latest financial reports, Kangstem Biotech Co. Ltd (217730) has a cash flow conversion efficiency ratio of -0.056x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.47 Billion ≈ $-2.35 Million USD) by net assets (₩62.25 Billion ≈ $42.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Kangstem Biotech Co. Ltd to measure how many days the company can operate on defensive assets alone.

Kangstem Biotech Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Kangstem Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kangstem Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kangstem Biotech Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Epsilon Energy Ltd NASDAQ:EPSN	0.081x
Circus SE XETRA:CA1	N/A
Tung Thih Electronic Co Ltd TWO:3552	0.091x
Boa Safra Sementes S.A SA:SOJA3	-0.074x
Dollar Industries Limited NSE:DOLLAR	0.049x
Seoul Broadcasting System KO:034120	0.025x
Li Peng Enterprise Co Ltd TW:1447	0.034x
Freightcar America Inc NASDAQ:RAIL	0.066x

Annual Cash Flow Conversion Efficiency for Kangstem Biotech Co. Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Kangstem Biotech Co. Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 217730 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩69.06 Billion ≈ $46.80 Million	₩-11.68 Billion ≈ $-7.91 Million	-0.169x	+61.55%
2024-12-31	₩43.18 Billion ≈ $29.26 Million	₩-18.99 Billion ≈ $-12.87 Million	-0.440x	-18.65%
2023-12-31	₩44.52 Billion ≈ $30.17 Million	₩-16.50 Billion ≈ $-11.18 Million	-0.371x	+7.15%
2022-12-31	₩47.26 Billion ≈ $32.03 Million	₩-18.86 Billion ≈ $-12.78 Million	-0.399x	-59.89%
2021-12-31	₩68.07 Billion ≈ $46.13 Million	₩-16.99 Billion ≈ $-11.52 Million	-0.250x	+7.92%
2020-12-31	₩51.62 Billion ≈ $34.98 Million	₩-13.99 Billion ≈ $-9.48 Million	-0.271x	-43.92%
2019-12-31	₩70.72 Billion ≈ $47.93 Million	₩-13.32 Billion ≈ $-9.03 Million	-0.188x	+21.73%
2018-12-31	₩47.69 Billion ≈ $32.32 Million	₩-11.48 Billion ≈ $-7.78 Million	-0.241x	+46.94%
2017-12-31	₩23.47 Billion ≈ $15.91 Million	₩-10.65 Billion ≈ $-7.22 Million	-0.454x	-33.67%
2016-12-31	₩22.98 Billion ≈ $15.57 Million	₩-7.80 Billion ≈ $-5.28 Million	-0.339x	-89.64%
2015-12-31	₩21.24 Billion ≈ $14.39 Million	₩-3.80 Billion ≈ $-2.58 Million	-0.179x	--

About Kangstem Biotech Co. Ltd

KQ:217730 Korea Biotechnology

Market Cap

$160.30 Million

₩236.55 Billion KRW

Market Cap Rank

#17487 Global

#720 in Korea

Share Price

₩2515.00

Change (1 day)

-6.85%

52-Week Range

₩1171.00 - ₩4615.00

All Time High

₩18836.30